A. L. van Wezel

1.7k total citations · 1 hit paper
30 papers, 1.2k citations indexed

About

A. L. van Wezel is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, A. L. van Wezel has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 14 papers in Infectious Diseases and 12 papers in Epidemiology. Recurrent topics in A. L. van Wezel's work include Viral Infections and Immunology Research (15 papers), Viral gastroenteritis research and epidemiology (13 papers) and Respiratory viral infections research (8 papers). A. L. van Wezel is often cited by papers focused on Viral Infections and Immunology Research (15 papers), Viral gastroenteritis research and epidemiology (13 papers) and Respiratory viral infections research (8 papers). A. L. van Wezel collaborates with scholars based in Netherlands, Sweden and Canada. A. L. van Wezel's co-authors include G. van Steenis, Albert D. M. E. Osterhaus, Douglas G. Kilburn, P. van der Marel, Jonas Salk, Paul Albrecht, Petra de Vries, Harry O. Voorma, Rob van Binnendijk and F. G. C. M. UytdeHaag and has published in prestigious journals such as Nature, Clinical Infectious Diseases and Biotechnology and Bioengineering.

In The Last Decade

A. L. van Wezel

30 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Growth of Cell-strains and Primary Cells on Micro-carriers in Homogeneous Culture

1967 499 citations A. L. van Wezel Nature profile →

Peers

Countries citing papers authored by A. L. van Wezel

Since Specialization

Citations

This map shows the geographic impact of A. L. van Wezel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. L. van Wezel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. L. van Wezel more than expected).

Fields of papers citing papers by A. L. van Wezel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. L. van Wezel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. L. van Wezel. The network helps show where A. L. van Wezel may publish in the future.

Co-authorship network of co-authors of A. L. van Wezel

This figure shows the co-authorship network connecting the top 25 collaborators of A. L. van Wezel. A scholar is included among the top collaborators of A. L. van Wezel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. L. van Wezel. A. L. van Wezel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in Kenya. 1992 ·PubMed ·(unknown), J. Leeuwenburg, P. M. Tukei, A. L. van Wezel, Jacoba G. Kapsenberg, G. van Steenis, A Gałazka, S E Robertson, Derek J. S. Robinson	29
2	Comparison of Serum and Salivary Antibodies in Children Vaccinated with Oral Live or Parenteral Inactivated Poliovirus Vaccines of Different Antigen Concentrations 1991 ·Acta Paediatrica ·Shakila Zaman, B. Carlsson, F Jalil, Lotta Mellander, A. L. van Wezel, M Böttiger, Lars Hanson	13
3	Immunologic memory induced at birth by immunization with inactivated polio vaccine in a reduced schedule 1989 ·European Journal of Epidemiology ·T. A. Swartz, Rachel Handsher, P Stoeckel, J Drucker, Pierre Caudrelier, A. L. van Wezel, (unknown), Darrell Salk, Jonas Salk	26
4	Measles Virus Fusion Protein Presented in an Immune-stimulating Complex (Iscom) Induces Haemolysis-inhibiting and Fusion-inhibiting Antibodies, Virus-specific T Cells and Protection in Mice 1988 ·Journal of General Virology ·Petra de Vries, Rob van Binnendijk, P. van der Marel, A. L. van Wezel, Harry O. Voorma, Bo Sundquist, F. G. C. M. UytdeHaag, Albert D. M. E. Osterhaus	84
5	Inhibition of Measles Virus-Induced Cell—Cell Fusion with a Monoclonal Antibody Directed Against the Haemagglutinin 1987 ·Viral Immunology ·Petra de Vries, Rob van Binnendijk, P. van der Marel, E. C. Beuvery, A. L. van Wezel, Harry O. Voorma, (unknown), Albert D. M. E. Osterhaus	10
6	Characterization and fibrin-binding properties of different molecular forms of pro-urokinase from a monkey kidney cell culture 1986 ·Thrombosis Research ·G. Wijngaards, D.C. Rijken, A. L. van Wezel, E. Groeneveld, (unknown)	23
7	Different Secretory IgA Antibody Responses After Immunization with Inactivated and Live Poliovirus Vaccines 1984 ·Clinical Infectious Diseases ·L Å Hanson, B. Carlsson, F Jalil, B. S. Lindblad, (unknown), A. L. van Wezel	15
8	Standardization of Poliovirus Neutralizing Antibody Tests 1984 ·Clinical Infectious Diseases ·Paul Albrecht, G. van Steenis, A. L. van Wezel, Jonas Salk	78
9	Inactivated Poliovirus Vaccine: Current Production Methods and New Developments 1984 ·Clinical Infectious Diseases ·A. L. van Wezel, G. van Steenis, P. van der Marel, Albert D. M. E. Osterhaus	49
10	The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic. 1984 ·PubMed ·G. J. P. Schaap, (unknown), R A Coutinho, Jacoba G. Kapsenberg, A. L. van Wezel	36
11	Antigenicity and immunogenicity of poliovirus capsid proteins. 1983 ·PubMed ·A. L. van Wezel, P. van der Marel, (unknown), (unknown), (unknown)	10
12	Theoretical and practical considerations in the application of killed poliovirus vaccine for the control of paralytic poliomyelitis. 1981 ·PubMed ·Jonas Salk, A. L. van Wezel, P Stoeckel, G. van Steenis, M Schlumberger, M Meyran, (unknown), K Lapinleimu, M Böttiger, (unknown)	26
13	Production and potential use of monoclonal antibodies against polio viruses. 1981 ·PubMed ·Albert D. M. E. Osterhaus, A. L. van Wezel, (unknown), (unknown), (unknown)	3
14	The production of inactivated poliovaccine on serially cultivated kidney cells from captive-bred monkeys. 1980 ·PubMed ·A. L. van Wezel, (unknown), (unknown)	19
15	Killed poliovirus antigen titration in humans. 1978 ·PubMed ·Jonas Salk, (unknown), (unknown), P Stoeckel, Jean‐Loup Rey, M Schlumberger, (unknown), G. van Steenis, A. L. van Wezel, R Triau, Philippe Saliou, (unknown), Jean‐Paul Moreau, (unknown)	20
16	Improved Cell Dispersal Method by Low-Temperature Incubation of Tissue in a Trypsin-Citrate Solution 1972 ·Applied Microbiology ·A. L. van Wezel, (unknown), (unknown), (unknown), (unknown)	4
17	The Effect of Growth Rate in Continuous-flow Cultures on the Replication of Rubella Virus in BHK Cells 1970 ·Journal of General Virology ·Douglas G. Kilburn, A. L. van Wezel	16
18	Homogeneous cultivation of animal cells for the production of virus and virus products 1969 ·Biotechnology and Bioengineering ·(unknown), Douglas G. Kilburn, A. L. van Wezel	53
19	A steam‐sterilizable electrode of the galvanic type for the measurement of dissolved oxygen 1969 ·Biotechnology and Bioengineering ·(unknown), Douglas G. Kilburn, R. C. Righelato, A. L. van Wezel	6
20	Preparation of Soluble Pertussis Vaccine 1964 ·Nature ·(unknown), A. L. van Wezel, (unknown)	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact